Alkermes Inc. plc (ALKS)
NASDAQ · Manufacturing · Pharmaceutical preparations
$40.85+$0.0600 (+0.15%) on the dayAs of the close; data may be delayed.
ALKS price, last 12 months
Key stats
- Previous close
- $40.79
- Open
- $40.94
- Day range
- $40.49 – $41.12
- 52-week range
- $26.99 – $55.67
- Volume
- 2.6M
- Avg volume (20 days)
- 2.1M
- Market cap
- $6.9B
Performance
1W−5.9%
1M−16.9%
3M−25.8%
6M+36.5%
YTD+46.0%
1Y+46.9%
vs S&P 500, 1Y+30.1 pts
Technicals and fundamentals
About Alkermes Inc. plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $6.9B